APA (7th ed.) Citation

Hariprasad, S. M., Holz, F. G., Asche, C. V., Issa, A., Mora, O., Keady, S., . . . Simoens, S. (2025). Clinical and Socioeconomic Burden of Retinal Diseases: Can Biosimilars Add Value? A Narrative Review. Ophthalmology & Therapy, 14(4), 621. https://doi.org/10.1007/s40123-025-01104-3

Chicago Style (17th ed.) Citation

Hariprasad, Seenu M., Frank G. Holz, Carl V. Asche, Amine Issa, Oriol Mora, Simon Keady, Mourad F. Rezk, Phil Sarocco, and Steven Simoens. "Clinical and Socioeconomic Burden of Retinal Diseases: Can Biosimilars Add Value? A Narrative Review." Ophthalmology & Therapy 14, no. 4 (2025): 621. https://doi.org/10.1007/s40123-025-01104-3.

MLA (9th ed.) Citation

Hariprasad, Seenu M., et al. "Clinical and Socioeconomic Burden of Retinal Diseases: Can Biosimilars Add Value? A Narrative Review." Ophthalmology & Therapy, vol. 14, no. 4, 2025, p. 621, https://doi.org/10.1007/s40123-025-01104-3.